前列腺绿激光汽化术治疗良性前列腺梗阻伴帕金森病的疗效
Photoselective vaporization of the prostate for the treatment of benign prostatic obstruction in patients with Parkinsons disease

DOI: 10.6040/j.issn.1671-7554.0.2017.104

Keywords: 帕金森病,良性前列腺梗阻,前列腺绿激光汽化术,
Parkinsons disease,Photoselective vaporization of the prostate,Benign prostatic obstruction

Full-Text   Cite this paper   Add to My Lib

Abstract:

References

[1]	Nunes RV, Manzano J, Truzzi JC, et al. Treatment of benign prostatic hyperplasia[J]. Rev Assoc Med Bras(1992), 2017, 63(2): 95-99.
[2]	Tong YC. Which term to use: BPO or BPH?[J]. Low Urin Tract Symptoms, 2014, 6(2): 129.
[3]	Poewe W, Seppi K, Tanner CM, et al. Parkinson disease[J]. Nat Rev Dis Primers, 2017, 3(13): 1-21.
[4]	Ravn AH, Thyssen JP, Egeberg A. Skin disorders in Parkinsons disease: potential biomarkers and risk factors[J]. Clin Cosmet Investig Dermatol, 2017, 10: 87-92. doi: 10.2147/CCID.S130319.
[5]	Suchowersky O. Non-motor symptoms and parkinsonism[J]. Can J Neurol Sci, 2013, 40(1): 1-2.
[6]	Sakakibara R, Panicker J, Finazzi-Agro E, et al. A guideline for the management of bladder dysfunction in Parkinsons disease and other gait disorders[J]. Neurourol Urodyn, 2016, 35(5): 551-563.
[7]	吴志刚, 沈丽霞. 帕金森病患者下尿路功能障碍治疗研究进展[J]. 神经药理学报, 2014,4(4):36-41. WU Zhigang, SHEN Lixia. Treatment for lower urinary tract dysfunction in patients with Parkinsons disease[J]. Acta Neuropharmacologica, 2014, 4(4): 36-41.
[8]	Roth B, Studer UE, Fowler CJ, et al. Benign prostatic obstruction and parkinsons disease—should transurethral resection of the prostate be avoided?[J]. J Urol, 2009, 181(5): 2209-2213.
[9]	Kapoor S, Bourdoumis A, Mambu L, et al. Effective management of lower urinary tract dysfunction in idiopathic Parkinsons disease[J]. Int J Urol, 2013, 20(1): 79-84.
[10]	薛芃, 韩志兴, 王涛. 64例帕金森病伴膀胱尿道功能障碍的临床分析[J]. 中华全科医学, 2011,9(10): 1519-1520. XUE Peng, HAN Zhixing, WANG Tao. Clinical analysis of Parkinsons disease with urinary bladder dysfunction: a report of 64 cases[J]. Chinese Journal of General Practice, 2011, 9(10): 1519-1520.
[11]	Krahn HP, Morales PA. The effect of pudendal nerve anesthesia on urinary continence after prostatectomy[J]. J Urol, 1965, 94(3): 282-285.
[12]	Chen J, Wang M, Wang S, et al. 160-Watt lithium triboride laser vaporization versus transurethral resection of prostate: a prospective nonrandomized two-center trial[J]. Urology, 2012, 79(3): 650-654.
[13]	Kim EH, Larson JA, Andriole GL. Management of benign prostatic hyperplasia[J]. Annu Rev Med, 2016, 67(8): 137-151.
[14]	Macey MR, Raynor MC. Medical and surgical treatment modalities for lower urinary tract symptoms in the male patient secondary to benign prostatic hyperplasia: a review[J]. Semin Intervent Radiol, 2016, 33(3): 217-223.
[15]	Staskin DS, Vardi Y, Siroky MB. Post-prostatectomy continence in the parkinsonian patient: the significance of poor voluntary sphincter control[J]. J Urol, 1988, 140(1): 117-118.
[16]	Chandiramani VA, Palace J, Fowler CJ. How to recognize patients with parkinsonism who should not have urological surgery[J]. Br J Urol, 1997, 80(1): 100-104.
[17]	Wyndaele JJ, Kovindha A, Igawa Y, et al. Neurologic fecal incontinence[J]. Neurourol Urodyn, 2010, 29(1): 207-212.
[18]	Badri AV, Purohit RS, Skenazy J, et al. A review of lower urinary tract symptoms in patients with Parkinsons disease[J]. Curr Urol Rep, 2014, 15(9): 435-444.
[19]	Chen B, Fan G, Sun W, et al. Usefulness of diffusion-tensor MRI in the diagnosis of Parkinson variant of multiple system atrophy and Parkinsons disease: a valuable tool to differentiate between them?[J]. Clin Radiol, 2017. doi: 10.1016/j.crad.2017.02.005.

Full-Text